GPT Healthcare Share Price Target 2025, 2026, 2030, 2040, 2050

GPT Healthcare is a healthcare company situated in Eastern India, with hospitals in West Bengal and Tripura. The company provides a wide range of medical services under the name ILS Hospitals. These services cover many areas of healthcare, including intensive care, brain and nervous system treatments, kidney care, bone and joint care, internal medicine, diabetes treatment, brain surgery, diagnostic tests, women’s health, general and minimally invasive surgeries, stomach and digestive system care, heart care, children’s health, newborn care, and pharmacy services.

What is GPT Healthcare Ltd NSE: GPTHEALTH?

GPT Healthcare was founded in 1989 and is located in Kolkata, India. The GPT Group owns the company and operates under the brand name “ILS Hospitals.” It runs four hospitals across Eastern India, with over 560 beds in cities like Kolkata, Agartala, Dum Dum, and Howrah. These hospitals offer a wide range of medical services in more than 35 specialties, such as internal medicine, kidney treatment, surgery, women’s health, heart care, and more. The company has seen steady growth in its revenue and continues to expand its healthcare services to reach more people in the region.

Share price Target Tomorrow

The stock is around its all-time low price, and it is a strong support level, too. The price has fallen a lot in the previous days. So for buying, you should consider multiple confirmations. Till now, there is a very strong bearish candle that has formed, and for trend reversal, you should be very conservative. So, wait for the right opportunity for now.

Day	Minimum Price (Rs)	Maximum Price (Rs)
Tomorrow	-4	+6

GPT Healthcare share price Target 2025

According to a report from. It is one of the top healthcare companies in Eastern India, known for having a large number of hospitals and beds. The company has been working in this region for many years. It provides a wide variety of medical services, making it a healthcare provider with many specialties. This helps the company generate income from different areas. In addition to offering basic medical care, surgery, and emergency services, it also provides advanced treatments in specialized fields like nephrology, diabetology, and other complex healthcare services. In 2025, its share price target would be ₹242, as per our analysis.

By our prediction, its share price would be between ₹106 and ₹242 in 2025.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	106	242

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	153	187
February	129	172
March	120	180
April	113	183
May	106	186
June	117	200
July	125	205
August	138	210
September	154	218
October	171	225
November	172	230
December	181	242

GPT Healthcare share price Target 2026

It is a well-known healthcare company in Eastern India with many hospitals and beds. It runs several medium-sized hospitals that offer different types of medical care, focusing on general and advanced treatments. GHL has hospitals in Dum Dum, Salt Lake, and Howrah in West Bengal and Agartala in Tripura.

The company offers many medical services, including treatment for internal medicine, diabetes, kidney issues, general surgeries, women’s health, critical care, stomach problems, bone and joint care, heart care, brain and nerve treatments, children’s health, and newborn care. Each hospital also has diagnostic services and pharmacies for patients. In 2026, its share price target would be ₹380, as per our prediction.

Its share price would be between ₹181 and ₹380 in 2026, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	181	380

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	181	244
February	185	248
March	191	250
April	188	253
May	190	257
June	197	262
July	200	280
August	219	300
September	228	317
October	239	330
November	254	351
December	290	380

Share price Target 2027

The company has focused on the healthcare market in Eastern India, which is less developed than other areas, and it operates in three cities there. This has helped the company’s revenue grow quickly in recent years, and it has earned a good return on the money invested in the business last year.

The company’s hospitals in West Bengal are located in busy cities like Kolkata and Howrah, which have a lot of people. India also attracts medical tourists from nearby countries like Bangladesh, Nepal, and Bhutan, as people from these places prefer to come to India for good healthcare. Eastern India is well-suited for this medical travel because it is closer and cheaper compared to other parts of India, like the north and west, making it easier for people from nearby countries to get healthcare services.  In 2027, its share price target would be ₹570, as per our analysis.

By our prediction, its share price will be between ₹290 and ₹570 in 2027.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	290	570

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	290	387
February	298	397
March	300	408
April	321	430
May	329	441
June	348	458
July	370	480
August	390	498
September	400	510
October	428	534
November	457	543
December	488	570

Share price Target 2028

It offers affordable surgery and medical care, along with hospitals that have modern technology, expert doctors, and services like e-medical visas. Also, cities like Kolkata in West Bengal and Agartala in Tripura are well-situated to attract medical tourists from nearby countries like Bangladesh. Kolkata’s similar culture to Bangladesh makes it especially appealing to people coming for medical treatment. In 2028, its share price target would be ₹720, as per our prediction.

Its share price would be between ₹488 and ₹720 in 2028, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	488	720

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	488	570
February	497	580
March	511	598
April	527	621
May	538	628
June	551	640
July	568	652
August	571	660
September	580	686
October	590	700
November	632	708
December	661	720

Share price Target 2029

Based on these financial numbers, it is doing well and showing growth in important areas. The increase in earnings per share shows that the company is being managed well and making improvements in how it runs its business. The strong return on equity and return on capital employed mean that the company is using its money and investments effectively to make profits. Overall, it seems to be on a good path of growth and is expected to keep doing well in the future. In 2029, its share price target would be ₹910, as per our analysis.

By our prediction, its share price will be between ₹661 and ₹910 in 2029.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	661	910

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	661	728
February	675	735
March	678	747
April	683	756
May	690	769
June	697	780
July	710	791
August	718	825
September	727	831
October	730	845
November	758	880
December	770	910

GPT Healthcare share price Target 2030

It has strong financials and clear growth plans, making it a company with a promising future. This positions it well in the Indian healthcare industry. The company is also ready to grow, supported by its strong brand, wide variety of healthcare services, and the opportunity to expand into new markets. But also, the healthcare industry is very competitive, and changes in stock prices could cause some challenges. In 2030, its share price target would be ₹1141, as per our prediction.

Its share price would be between ₹770 and ₹1141 in 2030, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	770	1141

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	770	910
February	781	925
March	790	938
April	800	942
May	831	950
June	837	964
July	854	981
August	870	997
September	887	1020
October	930	1042
November	954	1075
December	1045	1141

Share price Target 2040

It plans to grow its network and add more beds, which could bring a lot of growth but also some risks with costs, time, and getting things done, which might affect cash flow and profits. The company also wants to offer new services like organ transplants and robotic surgery, which could help it stand out in the market but will require a lot of money, skills, and overcoming challenges like customer acceptance and competition.

It also has to deal with external and internal issues, like changing rules, competition, and the ongoing impact of COVID-19, all of which affect its ability to adjust. Even though the company is doing well financially, it’s important to keep track of important numbers, like profits, cash flow, and debt, to stay stable. Staying informed about market and rule changes is also important to keep up with new technology and stay competitive. In 2040, its share price target would be ₹2154, as per our analysis.

By our prediction, its share price would be between ₹1861 and ₹2154 in 2040.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	1861	2154

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1861	1920
February	1870	1931
March	1877	1942
April	1880	1968
May	1897	1975
June	1908	1987
July	1924	2011
August	1938	2024
September	1945	2042
October	1958	2074
November	1967	2088
December	1980	2154

Share price Target 2050

The company is making a good profit compared to its sales. But, its recent performance has not been very good. The stock has shown a loss in the last few months, and its value hasn’t changed much over the past year or longer. The company also has very little debt and some money saved up, which is a good sign.

But because the company isn’t showing much growth right now and its recent returns have been disappointing, it is considered just an average option for people looking to invest for the long term. Before deciding to invest a lot of money, it would be a good idea to do more research. In 2050, its share price target would be ₹3458, as per our prediction.

Its share price would be between ₹3021 and ₹3458 in 2050, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	3021	3458

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	3021	3087
February	3028	3111
March	3042	3135
April	3051	3148
May	3060	3159
June	3068	3171
July	3075	3188
August	3089	3200
September	3122	3254
October	3155	3287
November	3174	3290
December	3254	3458

Should I buy GPT Healthcare stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	106	242
2026	181	380
2027	290	570
2028	488	720
2029	661	910
2030	770	1141
2040	1861	2154
2050	3021	3458

At the current time, the stock is not doing well; it is at its all-time low price. The company has plans for the future, like expanding its services and bringing in more medical tourists, but its recent performance has not been great. If you’re thinking about buying the stock soon, it might be a good idea to wait. For those looking to invest for the long term, the company’s growth potential looks good, but it’s important to be cautious due to the current lack of growth and some risks that could come up in the future.

GPT Healthcare earning results

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales +	212	243	337	361	400	405
Expenses +	176	194	263	287	312	319
Operating Profit	36	49	74	74	88	86
OPM %	17%	20%	22%	21%	22%	21%
Other Income +	4	6	5	6	5	9
Interest	14	14	11	9	7	4
Depreciation	11	12	14	15	18	19
Profit before tax	15	29	54	56	68	71
Tax %	26%	27%	23%	30%	30%
Net Profit +	11	21	42	39	48	50
EPS in Rs	6.11	11.76	5.21	4.88	5.82	6.07
Dividend Payout %	0%	47%	0%	102%	60%

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
22.47	5.13	2.56%	47.10	6.00	0.55%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
GPT Healthcare Ltd	23.46	5.13	2.56%
Max Healthcare Institute Ltd	90.97	11.44	0.15%
Apollo Hospitals Enterprise Ltd	98.31	12.07	0.26%
Fortis Healthcare Ltd	77.60	5.43	0.16%

Is GPT Healthcare stock good to buy? (Bull case & bear case)

Bull Case:

• Its revenue grew by 10.85% last year, and its profits increased by 22.46%.
• The company has strong profitability with a 24.89% Return on Equity (ROE), which means it’s good at making money with the resources.
• The stock is priced lower than many others in the market, which could mean it’s a good deal.
• The company pays about 54.2% of its profits as dividends to shareholders, which is attractive to investors who want income from their investments.

Bear Case:

• The stock has dropped by 9.86% over the last year and 25.93% in the last three months. This shows that it can be unstable and risky.
• The promoters have reduced their holdings by 34.4% over the last three years. This might indicate a lack of confidence in the company’s future.
• The healthcare industry is very competitive, and it faces competition from many other companies, which could make it harder for it to keep growing.

Conclusion

The stock is currently at a low point, which might be a good time to buy, but it’s important to be careful because the stock has been falling recently. The company has the potential to grow in the next few years, especially with its plans to expand in Eastern India and attract medical tourists. In the next few years, it might grow as it offers more advanced services. In the long term, the company’s success will depend on how well it manages its growth plans and deals with market changes. Investors should be careful in the short term but might consider it a good long-term investment if they watch its financial health and competition.

FAQs